1. Jonkers, J, Meuwissen, R, van der Gulden, H, van der Valk, M, Berns, A. . Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. In Nature genetics, 29, 418-25. doi:. https://pubmed.ncbi.nlm.nih.gov/11694875/
2. Ossa, Carlos Andrés, Molina, Gustavo, Cock-Rada, Alicia María. 2016. Li-Fraumeni syndrome. In Biomedica : revista del Instituto Nacional de Salud, 36, 182-7. doi:10.7705/biomedica.v36i3.2793. https://pubmed.ncbi.nlm.nih.gov/27622479/
3. Daniel, Jonathan C, Smythe, W Roy. . Gene therapy of lung cancer. In Seminars in surgical oncology, 21, 196-204. doi:. https://pubmed.ncbi.nlm.nih.gov/14508853/
4. Gupta, Amit, Shah, Karan, Oza, Manisha J, Behl, Tapan. 2018. Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 109, 484-492. doi:10.1016/j.biopha.2018.10.155. https://pubmed.ncbi.nlm.nih.gov/30551517/
5. Nahari, Dorit, McDaniel, Lisa D, Task, Laurie B, Velasco-Miguel, Susana, Friedberg, Errol C. . Mutations in the Trp53 gene of UV-irradiated Xpc mutant mice suggest a novel Xpc-dependent DNA repair process. In DNA repair, 3, 379-86. doi:. https://pubmed.ncbi.nlm.nih.gov/15010313/
6. Blackburn, Anneke C, Jerry, D Joseph. 2002. Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer? In Breast cancer research : BCR, 4, 101-11. doi:. https://pubmed.ncbi.nlm.nih.gov/12052252/
7. Roth, J A. . Gene replacement strategies for cancer. In Israel journal of medical sciences, 32, 89-94. doi:. https://pubmed.ncbi.nlm.nih.gov/8631656/
智鼠故事 
